Keir Starmer told around 200 executives that he plans to rip up bureaucracy that blocks investment. Read more here.

Dr. Baldoni’s career includes 29 years in R&D at GSK, where he served as Senior Vice President of ... "We are pleased to welcome Dr. Baldoni to our Scientific Advisory Board," said Vin Singh, CEO of ...

Keir Starmer vows to scrap regulation as PM unveils £50bn of investment in UK at key summit - Keir Starmer to welcome more ...

Uncertainty around the event and suspected tax changes in the upcoming budget has left many investors in the dark.

Stellantis CEO Carlos Tavares on Monday declined to rule out job cuts and said keeping up with Chinese competition and ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...

The Financial Times top stories cover HSBC's targeted cost-cutting strategy focusing on senior bankers, the UK government's ...